Bridgefront Capital’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Buy
+34,436
New +$408K 0.09% 333

Other funds holding ZVRA

Bridgefront Capital's ZVRA Position: Q3 2026 in Review

Bridgefront Capital opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 34,436 shares worth $378K. The stake represents 0.09% of the portfolio and ranks #333 among its holdings.

173 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Bridgefront Capital held 34,436 shares of Zevra Therapeutics worth $378K as of Q3 2026.
  • Zevra Therapeutics was a new Bridgefront Capital position in Q3 2026.
  • Zevra Therapeutics made up 0.09% of Bridgefront Capital's portfolio in Q3 2026, its #333 holding.
  • 173 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Bridgefront Capital's 13F filing for Q3 2026, filed 16 Nov 2026.